Our Portfolio

Hugel Pharma

Portfolio Link Arrow www.hugel-aesthetics.com
  • THEME

    Private Equity

  • STATUS

    Former

Hugel (KOSDAQ: 145020) is a publicly traded biopharmaceutical company in Korea that primarily focuses on the manufacturing and selling of botulinum toxin (BTX – widely known as Botox) and hyaluronic acid dermal fillers (HA Fillers).

 

Bain Capital Healthcare
We have built one of the largest and deepest healthcare investing teams in the world. Click here to read more about the breadth and legacy of our efforts.

_